DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
173 hedge funds and large institutions have $1.25B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
-29
Holders Change %
-14.36%
% of All Funds
3.04%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
28
Increased
64
Reduced
58
Closed
56
Calls
$15.1M
Puts
$4.49M
Net Calls
+$10.6M
Net Calls Change
+$8.12M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$26.1M |
| 2 |
CC
Commodore Capital
New York
|
+$26.1M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$25.2M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$16.1M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$15.7M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$58.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$55.8M |
| 3 |
PA
Perceptive Advisors
New York
|
-$29.9M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$18.5M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$16.9M |
